<DOC>
	<DOCNO>NCT00451412</DOCNO>
	<brief_summary>This study design provide efficacy safety data certoparin prophylaxis venous thromboembolism immobilize , acutely ill medical patient .</brief_summary>
	<brief_title>A Comparison Certoparin Unfractionated Heparin Prevention Thromboembolic Events Acutely Ill Medical Patients</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Hospitalized medical patient 70 year age old 2 . Acute medical illness significant decrease mobility expect least 4 day ( patient bedridden able walk short distance ) 3. write informed consent 1. immobilization longer 3 day prior randomization 2. prior major surgery , trauma invasive procedure within last 4 week include injury operation central nervous system 3. expect major surgical invasive procedure within next 3 week randomization 4 . LMWH/heparin administration longer 48 hour 5 day prior randomization 5. immobilization due cast fracture 6. indication anticoagulatory thrombolytic therapy 7. acute symptomatic DVT / PE 8. know hypersensitivity study drug drug similar chemical structure 9 . Acute history heparin induce thrombocytopenia type II ( HIT II ) Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Venous thromboembolism</keyword>
	<keyword>Medical patient</keyword>
	<keyword>Heparin</keyword>
	<keyword>Low molecular weight heparin</keyword>
	<keyword>Deep vein thrombosis</keyword>
	<keyword>Certoparin</keyword>
	<keyword>Embolism Thrombosis</keyword>
</DOC>